CSIMarket
 
Corcept Therapeutics Inc  (NASDAQ: CORT)
Other Ticker:  
 
 

Corcept Therapeutics Inc Growth Comparisons

Select each growth Category to receive further Information



CORT Revenue Growth Rate Comparisons Company Industry Sector S&P 500
Y / Y Revenue Growth (Q3 MRQ) 47.69 % 9.75 % 7.3 % 3.85 %
Q / Q Revenue Growth (Q3 MRQ) 11.45 % 3.93 % 2.76 % 0.31 %
Y / Y Revenue Growth (for 12 months ending Q3 TTM) 39.67 % 2.77 % 5.66 % %
Seq. Revenue Growth (for 12 months ending Q3 TTM) 10.35 % 2.56 % 1.77 % 1.08 %
Revenue 5 Year Average Growth 13.93 % 8.81 % 7.98 % 7.75 %


CORT's Growth Comparisons in III. Quarter 2024




Corcept Therapeutics Inc showed respectable 47.69% year on year rise of Revenue in the third quarter 2024, comparing favorably to the 9.75% growth in the Major Pharmaceutical Preparations industry, and 7.3% growth in the Healthcare sector. Above the average sales gains in the Healthcare and in the Major Pharmaceutical Preparations industry, helped to elevate overall market growth to 3.85%.

Top-line improved by 11.45% from the second quarter. Looking into annual sales rise of 13.93%, and S & P 500's average yearly sales growth is 7.75% over the five years, including only Businesses with the third quarter 2024 Results. Corcept Therapeutics Inc grew faster than the market.

CORT Growth Rates by Company's Segments

Segment Name
Y / Y
Seq.
Total
47.69 %
11.45 %


Growth Rates of CORT's Income in the third quarter 2024


CORT Operating Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Operating Income Change (Q3 MRQ) 49.46 % 90.42 % 80.05 % 4.22 %
Seq. Operating Income Change (Q3 MRQ) 30.92 % 42.18 % 33.32 % -2.5 %
Y / Y Operating Income Growth (Q3 TTM) 46.12 % -32.14 % -5.83 % 9.02 %
Seq. Operating Income Growth (Q3 TTM) 12.05 % 29.44 % 19.93 % 1.36 %
Operating Income 5 Year Avg. Change 3.69 % 3.05 % 6.19 % 9.17 %


Income from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Income from Cont. Ops. Change (Q3 MRQ) 49.78 % 161.72 % 285.84 % -1.75 %
Seq. Income from Cont. Ops. Change (Q3 MRQ) 32.94 % 59.34 % 119.47 % -8.86 %
Y / Y Income from Cont. Ops. Change (Q3 TTM) 54.59 % -1.76 % 26.31 % 8.51 %
Seq. Income from Cont. Ops. Change (Q3 TTM) 12.42 % 42.09 % 56.61 % -0.08 %
Income from Cont. Ops. 5 Year Avg. Change 6.95 % -3.69 % -9.67 % 7.35 %

CORT Net Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Net Income Growth (Q3 MRQ) 49.78 % -39.13 % 8.01 % -6.44 %
Q / Q Net Income Growth (Q3 MRQ) 32.94 % 59.12 % 133.05 % -6.89 %
Y / Y Net Income Change (Q3 TTM) 54.59 % -41.18 % -10.96 % 4.96 %
Seq. Net Income Change (Q3 TTM) 12.42 % -26.14 % 2.56 % -1.41 %
Net Income 5 Year Avg. Growth 6.95 % 4.4 % -3.34 % 7.5 %

CORT's EPS Growth Rates


EPS from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS from Cont. Ops. Change (Q3 MRQ) 45.16 % 180.79 % 285.84 % -1.75 %
Seq. EPS from Cont. Ops. Change (Q3 MRQ) 32.35 % 56.64 % 119.47 % -8.86 %
Y / Y EPS from Cont. Ops. Change (Q3 TTM) 54.42 % - - -
Seq. EPS from Cont. Ops. Change (Q3 TTM) 11.43 % - - -6.57 %
EPS from Cont. Ops. 5 Year Avg. Growth 9.43 % -16.72 % -9.67 % 7.35 %



CORT EPS Net Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS Net Growth (Q3 MRQ) 46.43 % -34.7 % 8.01 % -6.44 %
Q / Q EPS Net Growth (Q3 MRQ) 28.13 % 56.43 % 133.05 % -6.89 %
Y / Y EPS Net Change (for 12 months ending Q3 TTM) - - - 44.84 %
Seq. EPS Net Change (for 12 months ending Q3 TTM) 11.35 % - - -6.16 %
EPS Net 5 Year Avg. Change 9.39 % 4.4 % -3.34 % 7.5 %



Corcept Therapeutics Inc showed impressive 46.43% year on year rise in the third quarter to $0.41, despite the -34.7% inMajor Pharmaceutical Preparations industry, Healthcare sector grew 8.01%. Although Major Pharmaceutical Preparations industry's earnings per share were softer then -6.44% overall market growth, Corcept Therapeutics Inc and the Healthcare sector have delivered above the average market earnings per share.

The company's sequential bottom-line increase was 28.13% from the second quarter. Average annual income per share rise for Corcept Therapeutics Inc is 9.39%, while S & P 500's average yearly income per share growth is 7.5% over the five years, including only Businesses with the third quarter 2024 earnings results.

CORT Cash Flow Growth Rates


Free Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Free Cash Flow Change (Q3 MRQ) 39.54 % 38.16 % 37.8 % -41.98 %
Seq. Free Cash Flow Change (Q3 MRQ) 79.27 % 201.6 % 107.49 % -35.8 %
Y / Y Free Cash Flow Change (Q3 TTM) -6.4 % 1 % 4.24 % 3.46 %
Seq. Free Cash Flow Change (Q3 TTM) 16.91 % 8.1 % 8.11 % -10.66 %
Free Cash Flow 5 Year Avg. Change 1.92 % 11.97 % 7.1 % 11.97 %

Net Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Net Cash Flow Change (Q3 MRQ) - - -79.59 % -
Seq. Net Cash Flow Change (Q3 MRQ) - - - -
Y / Y Net Cash Flow Change (Q3 TTM) -58.59 % - - -
Seq. Net Cash Flow Change (Q3 TTM) - - - -
Net Cash Flow 5 Year Avg. Change 45.64 % 1.42 % 10.99 % -33.52 %

Capital Expenditures Company Industry Sector S&P 500
Y / Y Capital Expenditures Change (Q3 MRQ) 4318.92 % 1.99 % 1.51 % 2.82 %
Seq. Capital Expenditures Change (Q3 MRQ) 293.03 % 9.65 % 5.72 % 3.24 %
Y / Y Capital Expenditures Change (Q3 TTM) 1106.47 % 5.59 % 3.04 % 69.35 %
Seq. Capital Expenditures Change (Q3 TTM) 352.76 % 1.69 % 2.03 % -0.5 %
Capital Expenditures 5 Year Avg. Change -14.15 % 13.67 % 9.35 % 8.86 %

Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 







Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com